ECM1 and ovarian cancer: It has been reported that ECM1 was over-expressed in many solid tumors, such as breast cancer, thyroid cancer, cholangiocarcinoma, lung cancer, bladder cancer, ovarian cancer, colorectal cancer, and was related to chemo-resistance, tumor invasion, metastasis and poor prognosis [17–26].